Cargando…
Metabolic Volume Measurements in Multiple Myeloma
Multiple myeloma (MM) accounts for 10–15% of all hematologic malignancies, as well as 20% of deaths related to hematologic malignant tumors, predominantly affecting bone and bone marrow. Positron emission tomography/computed tomography with 18F-fluorodeoxyglucose (FDG-PET/CT) is an important method...
Autores principales: | Takahashi, Maria Emilia Seren, Lorand-Metze, Irene, de Souza, Carmino Antonio, Mesquita, Claudio Tinoco, Fernandes, Fernando Amorim, Carvalheira, José Barreto Campello, Ramos, Celso Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703741/ https://www.ncbi.nlm.nih.gov/pubmed/34940633 http://dx.doi.org/10.3390/metabo11120875 |
Ejemplares similares
-
Computed tomography–based skeletal segmentation for quantitative PET metrics of bone involvement in multiple myeloma
por: Takahashi, Maria E.S., et al.
Publicado: (2020) -
(99m)Tc-sestamibi SPECT/CT and (18)F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma
por: Mosci, Camila, et al.
Publicado: (2020) -
Proposal for a Quantitative (18)F-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple Myeloma
por: Takahashi, Maria E. S., et al.
Publicado: (2019) -
Fractal Characteristics of May-Grünwald-Giemsa Stained Chromatin Are Independent Prognostic Factors for Survival in Multiple Myeloma
por: Ferro, Daniela P., et al.
Publicado: (2011) -
Obesity as a Possible Risk Factor for Progression from Monoclonal Gammopathy of Undetermined Significance Progression into Multiple Myeloma: Could Myeloma Be Prevented with Metformin Treatment?
por: da Cunha Júnior, Ademar Dantas, et al.
Publicado: (2021)